Gentamicin use in neonates: should we have a change of practice?

Abstract

Background

Gentamicin, one of the most commonly used antibiotics in neonates, has potential toxicity. This study was performed to determine the incidence of potential toxicity of gentamicin in term and preterm neonates.

Methods

A one-year retrospective study in neonates admitted to Special Baby Care Units at University Hospital of North Durham and Darlington Memorial Hospitals. We reviewed each admission and looked through the case notes in detail to document information about gentamicin administration, dosage and elevated gentamicin levels in the blood. Pre-third dose gentamicin levels >2 mg/L were classified as elevated.

Results

Overall, 192 babies (83 term and 109 preterm) had documented gentamicin levels. Of these, 43% (84/192) manifested elevated gentamicin levels. Of the babies with elevated gentamicin levels, 67% (56/84) weighed less than 2.5 kg. When a combination of gestation period and weight was considered, 61% (51/84) of preterm infants weighing <2.5 kg had elevated levels whereas only one term infant <2.5 kg exhibited elevated levels.

Conclusion

Preterm neonates and specifically low birth weight neonates tolerate gentamicin poorly. Dosage and/or interval of administration of the medication may need modification in this group to minimise toxicity.

Keywords

Antibiotic gentamicin preterm toxicity

Get full access to this article

View all access options for this article.

References

Polin

. Committee on Foetus and Newborn. Management of neonates with suspected or proven early onset bacterial sepsis. Pediatrics 2012; 129: 1006–1015.

Muller-Pebody

Johnson

Heath

. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011; 96: F4–F8.

Edmund Hey and Northern Neonatal Network. Neonatal formulary NNF6 , 6th ed. London: BMJ Books/Wiley-Blackwell, pp. 120–120.

Paediatric Formulary Committee. BNF for Children 2011–2012 (Pharmaceutical Press), UK: British Medical Association/Royal Pharmaceutical Society/Royal College of Paediatrics and Child Health/Neonatal and Paediatric Pharmacists Group, pp. 278–278.

Rao

Ahmed

Hagan

. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochr Database Syst Rev 2006; 25: CD005091–CD005091.

Finitzo-Hieber

McCracken

Jr Brown

. Prospective controlled evaluation of auditory function in neonates given netilmicin or amikacin. J Pediatr 1985; 106: 129–136.

Mattie

Craig

Pechere

. Determinants of efficacy and toxicity of aminoglycosides. J Antimicrobial Chemother 1989; 24: 281–293.

Mohamed

Nielsen

Cars

. Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants. Antimicrob Agents Chemother 2012; 56: 179–188.

NICE guideline CG 149. Antibiotics for early-onset neonatal infection (CG 149), London: NICE, 2012.

10.

NHSP Clinical Group – Sutton G, Wood S, Feirn R, et al. Newborn hearing screening and assessment: guidelines for surveillance and audiological referral of infants & children following the newborn hearing screen: Version 5.1 June 2012, http://hearing.screening.nhs.uk/surveillanceguidelines (accessed 29 October 2012).